• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[绝经后的心血管风险:神话、悖论还是现实。临床观察与统计数据解读的重要性]

[Cardiovascular risk in menopause: myth, paradox or reality. The importance of clinical observations vs statistical data interpretation].

作者信息

Tomás Abadal L

出版信息

Rev Esp Cardiol. 1999 Jul;52(7):463-6. doi: 10.1016/s0300-8932(99)74952-3.

DOI:10.1016/s0300-8932(99)74952-3
PMID:10439668
Abstract

Coronary mortality among men is higher than in women in all age groups. Women seem to be protected from coronary disease. After the age of 50, coronary mortality increases fast in women and slows down in men, so that the mortality curves tend to join at some level. This fact led to believe that menopause had some influence over the non-proportional increase of coronary risk in women. Estrogens would be responsible for this protection before menopause and their further decrease would be the cause of higher coronary mortality. Mortality rate data, taken from a population with a high rate disease or a low rate disease, do not prove the above statement. For this reason it is said to by a myth. If it were a myth, then to try to prevent by administrating a substitute of these estrogens during menopause would be a paradox. If we accept that coronary atherosclerosis disease has many etiological factors, we should conclude that, besides hormones, there are other elements involved. The kind of personality, the way of life together with genetic factors related to gender would explain differences in frequency and mortality due to coronary heart disease, which, in this case, clearly advocates for women.

摘要

在所有年龄组中,男性的冠状动脉死亡率均高于女性。女性似乎对冠状动脉疾病具有一定的抵御能力。50岁之后,女性的冠状动脉死亡率迅速上升,而男性的死亡率上升速度则放缓,因此死亡率曲线在某一水平上趋于相交。这一事实让人认为,更年期对女性冠状动脉风险的非比例性增加存在一定影响。雌激素在绝经前起到这种保护作用,而其进一步减少则是冠状动脉死亡率升高的原因。从高发病率或低发病率人群中获取的死亡率数据并不能证明上述说法。因此,这被认为是一个误区。如果这是一个误区,那么在更年期通过服用这些雌激素的替代品来进行预防就会自相矛盾。如果我们承认冠状动脉粥样硬化疾病有多种病因,就应该得出结论,除了激素之外,还有其他因素在起作用。性格类型、生活方式以及与性别相关的遗传因素可以解释冠心病在发病率和死亡率上的差异,在这种情况下,女性显然更具优势。

相似文献

1
[Cardiovascular risk in menopause: myth, paradox or reality. The importance of clinical observations vs statistical data interpretation].[绝经后的心血管风险:神话、悖论还是现实。临床观察与统计数据解读的重要性]
Rev Esp Cardiol. 1999 Jul;52(7):463-6. doi: 10.1016/s0300-8932(99)74952-3.
2
[Cardiovascular risk factors and prevention in women: similarities and differences].[女性心血管危险因素与预防:异同]
Ital Heart J Suppl. 2001 Feb;2(2):125-41.
3
Myocardial infarction in women.女性心肌梗死
Epidemiol Rev. 1983;5:67-95. doi: 10.1093/oxfordjournals.epirev.a036265.
4
Age at natural menopause and cause-specific mortality.自然绝经年龄与特定病因死亡率。
Am J Epidemiol. 2005 Dec 1;162(11):1089-97. doi: 10.1093/aje/kwi324. Epub 2005 Oct 12.
5
Sex hormones and cardiovascular risk.性激素与心血管风险。
Hum Reprod. 1992 Feb;7(2):162-7. doi: 10.1093/oxfordjournals.humrep.a137610.
6
Age at menopause as a risk factor for cardiovascular mortality.绝经年龄作为心血管疾病死亡率的一个风险因素。
Lancet. 1996 Mar 16;347(9003):714-8. doi: 10.1016/s0140-6736(96)90075-6.
7
Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.绝经后女性动脉粥样硬化的性别特异性特征:危险因素、临床病程及预防策略。
Climacteric. 2007 Oct;10 Suppl 2:16-20. doi: 10.1080/13697130701602712.
8
[Coronary disease in women: The role of sexual hormones].[女性冠心病:性激素的作用]
Ann Cardiol Angeiol (Paris). 2016 Dec;65(6):404-410. doi: 10.1016/j.ancard.2016.10.007. Epub 2016 Nov 1.
9
[Menopause: Hypertension and vascular disease].[绝经:高血压与血管疾病]
Hipertens Riesgo Vasc. 2018 Apr-Jun;35(2):77-83. doi: 10.1016/j.hipert.2017.11.001. Epub 2018 Feb 1.
10
DHEA, important source of sex steroids in men and even more in women.脱氢表雄酮(DHEA),男性性激素的重要来源,在女性中甚至更为重要。
Prog Brain Res. 2010;182:97-148. doi: 10.1016/S0079-6123(10)82004-7.